Results

Total Results: 1,884 records

Showing results for "states".
Users also searched for: statin

401. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States …  Key Facts: COPD is the third most common cause of death and chronic complications in the United States … FDA, the OCS Lung would be the only portable, warm-blood perfusion system available in the United States … Diffusion: The system is in the innovation phase in the United States.

402. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
     October 01, 2016 - guidelines advocating limitations of seclusion or restraints as much as possible,6 data in the United States … Approximately half of the studies were conducted in the United States. … for the single low SOE intervention, risk assessment,44,53 were both conducted outside the United States … This finding implies that the applicability of findings from outside the United States may be questioned … United States General Accounting Office Report to Congressional Requesters.

403. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
     January 01, 2014 - The draft report states in its summary:Given the rarity of these diseases individually, there are few … the statement be deleted, and that a sentence be added at the end of the previous paragraph that states … In our view, aggressiveness could mean any and all of those the reviewer states. … The text reflects the shortage of Cerezyme and Fabrazyme in the United States: “Shortages of Cerezyme … ® and Fabrazyme® in the United States were reported by the manufacturer in Fall 2011.

404. uterine-fibroids-protocol-160301 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
     March 01, 2016 - leiomyomata), benign smooth muscle tumors of the uterus, during their reproductive lifespan.1 In the United States … Across types of interventions, direct annual healthcare costs in the United States are projected to … Fertility of Women in the United States: June 2012. … The estimated annual cost of uterine leiomyomata in the United States. … Inpatient hysterectomy surveillance in the United States, 2000-2004.

405. Evidence-based Practice Center Technical Brief Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
     July 28, 2010 - costs more than $150 billion annually in health care, disability, and related expenses in the United States … .2 The American Pain Society estimates that 9 percent of the United States adult population suffers … The biopsychosocial model is more appropriate than the biomedical model for disease states for which … The APS states that: Pain is maintained by multiple mechanisms; and its proper management can vary

406. children-special-needs-transition-protocol-131003 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/children-special-needs-transition_research-protocol.pdf
     October 01, 2013 - opinion and consensus recommendations for transitioning adolescents into adult care.1 The 2011 report states … The AAP states that “optimal health care is achieved when every person at every age receives health … Special Health Care Needs,14 less than half of the youth with special health care needs in the United States … We will catalogue information on transition care services from individual States and health care systems

407. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States … Currently, an oxytocin nasal spray 5 mL (40 IU/mL) bottle is available for use in the United States … Currently, an oxytocin 3 nasal spray 5 mL (40 IU/mL) bottle is available for use in the United States

408. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disabilities-quality-improvement-outcomes_research-protocol.pdf
     August 03, 2011 - We will also limit the literature to the United States and to the United Kingdom, Canada, Australia … and the Netherlands, where service delivery settings are more likely to be applicable to the United States … include: Participant Experience Survey Elderly/Disabled Version: A Technical Assistance Tool for States … tracking the quality of care for people with developmental disabilities and in making comparisons across States

409. Disposition of Comments for Use of Natriuretic Peptide Measurement in the Management of Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
     November 20, 2013 - A recent overview of General approaches to prognostic studies states the following: “Data from randomized … As the reviewer states, results from NT-pro-BNP assays are, by design, similar which simplifies the … Results –page 71 states that the time between the reference and the index test was considered in the … QUADAS The QUADAS help table for reviewers states that the interval between the index and reference

410. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - or for which some preliminary efficacy data in the target population are available) in the United States … The Mayo Foundation for Medical Education and Research (MFMER) states that T1DM risk factors include … MFMER states that all patients with T1DM require insulin therapy. … This is the first low-glucose suspend system in the United States and is said to “automatically stop … If approved in the United States, the drug would compete with laser photocoagulation and off-label

411. Disposition of Comments Report for Assessment and Management of Chronic Cough (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
     January 07, 2013 - The revised “Description of Included Studies” section for KQ2 states, “Thirty-three of the 48 studies … the US as suggested Peer Reviewer #2 Introduction Introduction: Page 27 of 196: focus on United States

412. Disposition of Comments Report for Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
     February 26, 2013 - Peer Reviewer 1 Introduction The introduction is well written and clearly states the burden of disease … This is a clinical phenomenon which happens in the United States and Europe. … ischemia.2 3 In addition, the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention4 states … The Working Group consists of experts in intravascular OCT from Asia, Europe, and the United States

413. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
     May 26, 2016 - Introduction section states that LUTS can result from BPH due to BOO or changes in smooth muscle tone … Reviewer #1 Discussion/ Conclusion Two minor observations: Page 30, lines 50 – 51: this sentence states … Peer Reviewer #1 Discussion/ Conclusion Finally, on Page 31, lines 20-21, the text states, "it is

414. Cancer-Anemia-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
     April 01, 2013 - These include epoetin alfa (Epogen®, Procrit®) and epoetin beta (not available in the United States … Effective Health Care States.

415. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States

416. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States

417. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States

418. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States

419. AHRQ's Evidence-based Practice Center Division Annual Report 2020: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2020.pdf
     January 01, 2020 - Acupuncture for Low Back Pain Why: Chronic pain is the leading cause of disability in the United States … Out-of-pocket payments for pain treatment in the United States is about $600 billion per year. … Who: Disadvantaged populations in the United States seeking preventive care, including racial and ethnic … Safety of Vaccines Used for routine Immunization in the United States.

420. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
     August 24, 2012 - Peer Reviewer #4 Methods Also, although the report states that it examined the grey literature, the … It states that two reviewers assessed articles and differences were resolved by consensus. … In the report, AHRQ states that a lawsuit initiated by the American Academy of Ophthalmology helped … The conclusion states: There is weak but consistent evidence that new bundled payment programs have … The report states the goal as "decreasing health spending while improving or maintaining the quality